Enter your login e-mail to the account
Search
- How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )